TABLE 3.
Distribution of species or genomovars and of putative transmissibility factors among the 112 sequential B. cepacia complex isolates recovered from 22 patients with CFe
Species or genomovar | No. of isolatesa (%) | No. of patientsb (%) |
esmR-positive isolates
|
cblA-positive isolates
|
||
---|---|---|---|---|---|---|
No.c (%) | No.d (%) | No.c (%) | No.d (%) | |||
Genomovar I | 27 (24.1) | 8 (36.4) | 0 | 0 | 14 (12.5) | 14 (51.9) |
B. multivorans | 11 (9.8) | 2 (9.0) | 0 | 0 | 0 | 0 |
B. cenocepacia | 54 (48.2) | 12 (52.2) | 28 (25.0) | 28 (51.9) | 1 (0.9) | 1 (1.85) |
recA subgroup A | 25 (22.3) | 6 (27.3) | 19 (17.0) | 19 (35.2) | 1 (0.9) | 1 (1.85) |
recA subgroup B | 29 (25.9) | 7 (31.8) | 9 (8.0) | 9 (16.7) | 0 | 0 |
B. stabilis | 19 (17.0) | 4 (18.2) | 0 | 0 | 0 | 0 |
B. vietnamiensis | 0 | |||||
Genomovar VI | 0 | |||||
B. ambifaria | 0 | |||||
B. anthina | 0 | |||||
B. pyrrocinia | 0 |
Number of isolates belonging to a specific genomovar or species (as percentage of the 112 isolates examined).
Number of patients infected with a genomovar/species (as percentage of the 22 patients examined). The sum of the percentage of patients infected with the different genomovars exceeds 100% since three patients harboured strains from more than one genomovar.
Number of isolates belonging to a specific genomovar or species with esmR or cblA genes (as percentage of the 112 isolates examined).
Number of isolates belonging to a specific genomovar or species with esmR or cblA genes (as percentage of number of isolates belonging to this specific genomovar or species).
Calculations were based on results shown in Table 1. (The genomovar status of isolate IST426 from patient L was not determined.)